AI Insight: Collegium Pharmaceutical’s current price of $36.08 is significantly below its high-confidence fair value estimate of $302.08, implying substantial upside potential. Strong profitability and liquidity contrast with low leverage and efficiency, indicating financial stability paired with operational risk. High Monte Carlo volatility and zero downside risk scenarios reflect asymmetric upside with limited near-term price decline risk.